Skip to main content

The Globe and Mail

Jean Coutu a stock with the right prescription

An exterior shot of Jean Coutu store in Longueuil, Quebec, May 2, 2012

Christinne Muschi

Validea's pick of the week provides a detailed report on a company that scores well in the stock-screening service's model portfolios. On, investors can analyze 1,000 Canadian stocks through 12 different guru-based models and get individual reports on each company. Globe Investor has a distribution agreement with Try it.

Quebec-based pharmacy retailer Jean Coutu Group Inc. operates 405 franchised stores across Québec, New Brunswick and Ontario under the banners of PJC Jean Coutu, PJC Clinique, PJC Santé and PJC Santé Beauté; also owns Pro Doc Ltd., which makes generic drugs. Its U.S. subsidiary merged with U.S. firm Rite Aid in 2007

It grew EPS by 32 per cent in most recent year, and has five-year growth rate of 11 per cent. JCP attracts strong interest from our Peter Lynch-based guru model because it trades for just 6.4 times TTM EPS and has 1.7 per cent dividend yield, which makes for a solid 0.5 yield-adjusted P/E-to-Growth ratio (using five-year growth rate).

Story continues below advertisement

With a very low debt/equity ratio of 2.9 per cent, JCP's return on capital is 59.8 per cent, one reason it gets some interest from the Joel Greenblatt-based model. It also as averaged a return on equity of more than 30 per cent over past 3 years

Click here for the complete breakdown of Validea's investing guru report.

Report an error

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨